Cargando…
Engineering of Cytolethal Distending Toxin B by Its Reducing Immunogenicity and Maintaining Stability as a New Drug Candidate for Tumor Therapy; an In Silico Study
The cytolethal distending toxin (CDT), Haemophilus ducreyi, is one of the bacterial toxins that have recently been considered for targeted therapies, especially in cancer therapies. CDT is an A-B2 exotoxin. Its catalytic subunit (CdtB) is capable of inducing DNA double strand breaks, cell cycle arre...
Autores principales: | Keshtvarz, Maryam, Mahboobi, Mahdieh, Kieliszek, Marek, Miecznikowski, Antoni, Sedighian, Hamid, Rezaei, Milad, Haghighi, Mohammad Ali, Zareh, Zahra, Rezaei, Ehsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624547/ https://www.ncbi.nlm.nih.gov/pubmed/34822569 http://dx.doi.org/10.3390/toxins13110785 |
Ejemplares similares
-
The Biology of the Cytolethal Distending Toxins
por: Guerra, Lina, et al.
Publicado: (2011) -
Dynamic Duo—The Salmonella Cytolethal Distending Toxin Combines ADP-Ribosyltransferase and Nuclease Activities in a Novel Form of the Cytolethal Distending Toxin
por: Miller, Rachel, et al.
Publicado: (2016) -
Inflammatory and Bone Remodeling Responses to the Cytolethal Distending Toxins
por: Belibasakis, Georgios N., et al.
Publicado: (2014) -
Uptake and Processing of the Cytolethal Distending Toxin by Mammalian Cells
por: DiRienzo, Joseph M.
Publicado: (2014) -
Revisiting bacterial cytolethal distending toxin structure and function
por: Chen, Henry, et al.
Publicado: (2023)